These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38927239)
1. Autoimmunity against Nucleus Ambiguous Is Putatively Possible in Both Long-COVID-19 and Vaccinated Subjects: Scientific Evidence and Working Hypothesis. D'Anna SE; Vitale AM; D'Amico G; Caruso Bavisotto C; Ambrosino P; Cappello F; Maniscalco M; Marino Gammazza A Biology (Basel); 2024 May; 13(6):. PubMed ID: 38927239 [TBL] [Abstract][Full Text] [Related]
2. Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity? Churilov LP; Normatov MG; Utekhin VJ Pathophysiology; 2022 Aug; 29(3):486-494. PubMed ID: 36136066 [TBL] [Abstract][Full Text] [Related]
4. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19. Marino Gammazza A; Légaré S; Lo Bosco G; Fucarino A; Angileri F; Conway de Macario E; Macario AJ; Cappello F Cell Stress Chaperones; 2020 Sep; 25(5):737-741. PubMed ID: 32754823 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099 [TBL] [Abstract][Full Text] [Related]
7. Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers. Borghi MO; Bombaci M; Bodio C; Lonati PA; Gobbini A; Lorenzo M; Torresani E; Dubini A; Bulgarelli I; Solari F; Pregnolato F; Bandera A; Gori A; Parati G; Abrignani S; Grifantini R; Meroni PL Front Immunol; 2022; 13():930074. PubMed ID: 35911726 [TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial. Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE; Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection as a trigger of autoimmune response. Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235 [TBL] [Abstract][Full Text] [Related]
10. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Ormiston CK; Świątkiewicz I; Taub PR Heart Rhythm; 2022 Nov; 19(11):1880-1889. PubMed ID: 35853576 [TBL] [Abstract][Full Text] [Related]
11. A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapies. Stoll S; Desai S; Levit E Mult Scler Relat Disord; 2023 Mar; 71():104574. PubMed ID: 36827874 [TBL] [Abstract][Full Text] [Related]
12. Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history. Lavezzo E; Pacenti M; Manuto L; Boldrin C; Cattai M; Grazioli M; Bianca F; Sartori M; Caldart F; Castelli G; Nicoletti M; Nieddu E; Salvadoretti E; Labella B; Fava L; Vanuzzo MC; Lisi V; Antonello M; Grimaldi CI; Zulian C; Del Vecchio C; Plebani M; Padoan A; Cirillo DM; Brazzale AR; Tonon G; Toppo S; Dorigatti I; Crisanti A Genome Med; 2022 Jun; 14(1):61. PubMed ID: 35689243 [TBL] [Abstract][Full Text] [Related]
13. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status. Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR Elife; 2021 Oct; 10():. PubMed ID: 34636722 [TBL] [Abstract][Full Text] [Related]
14. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins. Nunez-Castilla J; Stebliankin V; Baral P; Balbin CA; Sobhan M; Cickovski T; Mondal AM; Narasimhan G; Chapagain P; Mathee K; Siltberg-Liberles J Viruses; 2022 Jun; 14(7):. PubMed ID: 35891400 [TBL] [Abstract][Full Text] [Related]